Related Experiment Videos
Histopathogenesis of skin and subcutaneous injury induced by adriamycin
Plastic and Reconstructive Surgery
|April 1, 1979
Abstract:
Extravasation of Adriamycin from an intravenous needle or catheter can produce a progressive skin necrosis and deep painful ulceration. The pathological changes which result in this ulceration were studied in a rabbit model. The earliest changes include vascular obliteration and necrobiosis of collagen. At no point were inflammatory cells found to play a primary role.
Insights
Adriamycin extravasation causes skin necrosis and painful ulcers. Rabbit models show early vascular damage and collagen changes, with no primary inflammatory cell role in this Adriamycin-induced skin injury.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Adriamycin (doxorubicin) extravasation from intravenous lines can lead to severe skin necrosis and ulceration.
- Understanding the pathological mechanisms is crucial for managing this adverse event.
Purpose of the Study:
- To investigate the pathological changes resulting from Adriamycin extravasation in a rabbit model.
- To identify the earliest cellular and tissue responses to Adriamycin-induced skin injury.
Main Methods:
- A rabbit model was utilized to study the effects of Adriamycin extravasation.
- Histopathological examination focused on early tissue alterations.
Main Results:
- The earliest pathological findings included the obliteration of blood vessels.
- Necrobiosis (degeneration and death) of collagen was observed as an early change.
- Inflammatory cells were not found to be the primary drivers of the observed pathology.
Conclusions:
- Adriamycin extravasation initiates tissue damage through vascular compromise and collagen degradation.
- The pathogenesis of Adriamycin-induced skin necrosis in this model is primarily non-inflammatory in its early stages.